Tristate Gynecologic Oncology
As surgeons and cancer specialists, physicians at Tristate Gynecologic Oncology employ the latest treatments to deliver the most comprehensive, individualized care to cancer patients and their families.
Gynecologic Oncologists: We Know Surgery and Cancer Care
Gynecologic Oncologists are specialists trained in the diagnosis and treatment of cancers of the female reproductive tract, including malignancies of the ovaries, fallopian tubes, uterus, vulva, vagina, and cervix. Our physicians are also teachers and researchers, striving to improve both quantity and quality of life for our patients.
Importantly, studies (1) have shown that both surgical and survival outcomes are improved for the gynecologic malignancies when the surgery is performed by a gynecologic oncologist rather than an obstetrician/gynecologist or a general surgeon.
Advanced Training, Comprehensive Treatment
We're unique among cancer professionals. Our advanced training in surgery, including robotics, chemotherapy, radiation therapy, and supportive care allows us to provide comprehensive care to our patients.
Because of this expertise, gynecologic oncologists are often consulted for particularly difficult benign gynecologic surgeries as well. Our specialized practice strives to create an atmosphere that meets the comprehensive needs of both our patients and their families.
The mission of Tristate Gynecology Oncology is to provide compassionate, high-quality clinical care to women with gynecologic cancer.
Research Citations 1. Vernooij F, Heintstematic review. Gynecol Oncol 2007;105(3):801-12. 2. Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006;98(3):151-4. 3. Engelen MJ, Kos HE, Willemse PH, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006;106(3):589-98. 4. Eisenkop SM, Spirtos NM, Montag TW, et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992;47(2):203-9.